These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 23399986
1. Primary tumor PET/CT [¹⁸F]FDG uptake is an independent predictive factor for regional lymph node metastasis in patients with non-small cell lung cancer. Li M, Wu N, Zheng R, Liang Y, Liu Y, Zhang W, Li N, Zhao P. Cancer Imaging; 2013 Feb 07; 12(3):566-72. PubMed ID: 23399986 [Abstract] [Full Text] [Related]
2. Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer. Muto J, Hida Y, Kaga K, Ohtaka K, Okamoto S, Tamaki N, Nakada-Kubota R, Hirano S, Matsui Y. Anticancer Res; 2014 Feb 07; 34(2):805-10. PubMed ID: 24511016 [Abstract] [Full Text] [Related]
3. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis. Yoo IeR, Chung SK, Park HL, Choi WH, Kim YK, Lee KY, Wang YP. Biomed Mater Eng; 2014 Feb 07; 24(6):3091-103. PubMed ID: 25227018 [Abstract] [Full Text] [Related]
4. An Investigation of the Relationship Between 18F-FDG PET/CT Parameters of Primary Tumors and Lymph Node Metastasis in Resectable Non-small Cell Lung Cancer. Kandemir O, Demir F. Curr Radiopharm; 2024 Feb 07; 17(1):111-116. PubMed ID: 37644744 [Abstract] [Full Text] [Related]
5. 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study. Higashi K, Ito K, Hiramatsu Y, Ishikawa T, Sakuma T, Matsunari I, Kuga G, Miura K, Higuchi T, Tonami H, Yamamoto I. J Nucl Med; 2005 Feb 07; 46(2):267-73. PubMed ID: 15695786 [Abstract] [Full Text] [Related]
6. Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases. Nakamura H, Saji H, Marushima H, Kimura H, Tagaya R, Kurimoto N, Hoshikawa M, Takagi M. Ann Surg Oncol; 2015 Dec 07; 22 Suppl 3():S1388-93. PubMed ID: 25900205 [Abstract] [Full Text] [Related]
7. Prediction of true-negative lymph node metastasis in clinical IA non-small cell lung cancer by measuring standardized uptake values on positron emission tomography. Takenaka T, Yano T, Morodomi Y, Ito K, Miura N, Kawano D, Shoji F, Baba S, Abe K, Honda H, Maehara Y. Surg Today; 2012 Oct 07; 42(10):934-9. PubMed ID: 22864936 [Abstract] [Full Text] [Related]
8. Accuracy and predictive features of FDG-PET/CT and CT for diagnosis of lymph node metastasis of T1 non-small-cell lung cancer manifesting as a subsolid nodule. Lee SM, Park CM, Paeng JC, Im HJ, Goo JM, Lee HJ, Kang CH, Kim YW, Kim JI. Eur Radiol; 2012 Jul 07; 22(7):1556-63. PubMed ID: 22358427 [Abstract] [Full Text] [Related]
9. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study. Zhai X, Guo Y, Qian X. Med Sci Monit; 2020 Jun 02; 26():e922675. PubMed ID: 32483109 [Abstract] [Full Text] [Related]
10. The diagnostic ability of 18F-FDG PET/CT for mediastinal lymph node staging using 18F-FDG uptake and volumetric CT histogram analysis in non-small cell lung cancer. Lee JW, Kim EY, Kim DJ, Lee JH, Kang WJ, Lee JD, Yun M. Eur Radiol; 2016 Dec 02; 26(12):4515-4523. PubMed ID: 26943133 [Abstract] [Full Text] [Related]
11. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer. Nakanishi K, Nakamura S, Sugiyama T, Kadomatsu Y, Ueno H, Goto M, Ozeki N, Fukui T, Iwano S, Chen-Yoshikawa TF. BMC Cancer; 2021 Sep 02; 21(1):983. PubMed ID: 34474680 [Abstract] [Full Text] [Related]
12. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients. Herbrik M, Treffert J, Geiger B, Riegger C, Hartung V, Rosenbaum-Krumme SJ, Forsting M, Antoch G, Heusner TA. J Nucl Med; 2011 Oct 02; 52(10):1520-5. PubMed ID: 21908390 [Abstract] [Full Text] [Related]
13. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer. Miyasaka Y, Suzuki K, Takamochi K, Matsunaga T, Oh S. Eur J Cardiothorac Surg; 2013 Jul 02; 44(1):83-7. PubMed ID: 23233074 [Abstract] [Full Text] [Related]
14. Prognostic value of FDG uptake in primary inoperable non-small cell lung cancer. Tong AN, Han SR, Yan P, Gong H, Zhao H, Yao H, Wang YM. Med Oncol; 2014 Jan 02; 31(1):780. PubMed ID: 24326983 [Abstract] [Full Text] [Related]
15. The value on SUV-derived parameters assessed on 18F-FDG PET/CT for predicting mediastinal lymph node metastasis in non-small cell lung cancer. Liao X, Liu M, Li S, Huang W, Guo C, Liu J, Xiong Y, Zhang J, Fan Y, Wang R. BMC Med Imaging; 2023 Apr 05; 23(1):49. PubMed ID: 37020286 [Abstract] [Full Text] [Related]
16. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer. Li X, Zhang H, Xing L, Xu X, Xie P, Ma H, Zhang L, Chen M, Sun X, Xu W, Chen L, Yu J. Clin Lung Cancer; 2013 Sep 05; 14(5):568-73. PubMed ID: 23835164 [Abstract] [Full Text] [Related]
19. Tumor-to-liver standard uptake ratio using fluorine-18 fluorodeoxyglucose positron emission tomography computed tomography effectively predict occult lymph node metastasis of non-small cell lung cancer patients. Shi YM, Niu R, Shao XL, Zhang FF, Shao XN, Wang JF, Wang XS, Liu B, Yu WJ, Wang YT. Nucl Med Commun; 2020 May 05; 41(5):459-468. PubMed ID: 32187163 [Abstract] [Full Text] [Related]
20. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection. Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M. J Thorac Cardiovasc Surg; 2012 Dec 05; 144(6):1365-71. PubMed ID: 22883546 [Abstract] [Full Text] [Related] Page: [Next] [New Search]